Navigation Links
Patient Pain Management at a Glance
Date:4/12/2017

TORONTO, April 12, 2017 /PRNewswire/ -- Intronix Technologies will be launching "Myoguide DOC", a comprehensive software package designed to help clinicians who inject Botulinum Toxins, such as Botox®, Dysport® and Xeomin® to manage their patient's spasticity and pain.

Myoguide DOC is the first integrated graphics driven patient management system that helps clinicians to document all aspects of their patient's treatment and outcome tracking, while improving their ability to communicate. Save time, increase productivity, improve communication, and follow patient outcomes.

Myoguide DOC patient management for pain and spasticity and treatment outcome tracking
Myoguide DOC patient management for pain and spasticity and treatment outcome tracking

Intronix Technologies Corp. (http://www.intronixtech.com) is known for producing the Myoguide™ EMG Guided Injection System, which is designed to help clinicians injecting therapeutic Botox like drugs to manage pain and spasticity.  Myoguide works like a Geiger counter generating sound and signal display to help clinicians locate the optimal sites to inject medication to provide relief to their patients.

Myoguide DOC electronic medical record software allows clinicians to take control of their patients by documenting exactly what, where why and how, much medication is injected, on anatomically accurate graphics.  This provides an "at a glance" view of today's injections, as well as being able to show previous treatment encounters, colour coded by date.

Clinicians can select from a collection of existing spasticity syndromes with anatomical graphic panes, or create their own.  A library of pain, spasticity, and capability assessment questionnaires are built in to allow clinicians to assess, and track each patient's state of health over time.  Results are presented in graphical format on each patient's home page.

"Our market research supports DOC will be an essential tool for continuous patient management.  Providing treatment records at a glance, patient outcome tracking, and report writing makes DOC a powerful tool. 

"We are very fortunate for the opportunity to contribute another element to help clinicians who are treating patients suffering from pain and spasticity. Clinicians using DOC will have an easier time seeing how patients are progressing," says Dr. Evan Friedman, President of Intronix Technologies.

Myoguide DOC is a robust, environmentally friendly solution designed for medical practitioners looking to substantially eliminate paper from their practices. DOC can redefine patient care by offering tools with flexibility and scalability for doctor driven workflow that can lead to improved patient care. This simply could not happen in the old paper-based world.

"We are always pushing to innovate and build a better tools. Promoting and supporting innovation in the healthcare software sector is essential to improving patient and community care," said Dr. Friedman. "We will continue working with healthcare providers with vision and integrity, so we can all benefit from a more efficient health care delivery system."

About Intronix Technologies Corporation

Located just outside Toronto, Ontario, Intronix Technologies Corporation designs and produces progressive portable medical devices for neuromuscular diagnostics and treatment delivery.  Its innovations in injection guidance provide technology that drives clinical solutions to deliver confidence, improve workflow efficiency, and provide a better patient experience. Intronix Technologies is known for its innovative equipment, plus comprehensive customer-support programs that are developed to maximize the lifecycle value of equipment through responsive service, maintenance, and significant software support. For additional information about Intronix, please refer to www.intronixtech.com

Contact:
Dr. Evan Friedman
President, Intronix Technologies Corporation
+01-905-951-3361
154585@email4pr.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/patient-pain-management-at-a-glance-300438498.html


'/>"/>
SOURCE Intronix Technologies
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Digital Pharmacist Appoints Kevin Mayes as General Manager & Senior Vice President, Patient Solutions
2. China Proton Therapy Market & Forecast, 2021: Patients Treated at Proton Therapy Facility, Reimbursement Policy 2009-2021 - Research and Markets
3. Global Advanced Remote Patient Monitoring Systems Markets 2012-2021 - Research and Markets
4. Pharmacists Face Challenge of Balancing Patients with Chronic Pain and Opioid Abuse, Misuse
5. Allergan Teams Up With Media Mogul Wendy Williams to Debut the Patient Empowerment Campaign - Toilet Talk
6. Medivir Announces Positive Data From the Phase II Study of Remetinostat in Patients With Early-stage Cutaneous T-cell Lymphoma
7. Urgent Care Market Reaches $15 Billion as Locations, Patient Visits Rise
8. Italy Proton Therapy Market, Patients Treated at Proton Therapy Centers & Forecast
9. United States Proton Therapy Market & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers
10. HLT Announces First Patient Enrollments in a Feasibility Study of a New Transcatheter Aortic Valve Replacement System
11. Boston Childrens Hospital Goes Live With GetWellNetwork for Interactive Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Brady ... announced that its B-595 and B-7569 vinyl label materials received ... and warning labels are tested to remain intact and legible, for use on chemical ...
(Date:4/21/2017)... Colo. (PRWEB) , ... April 21, 2017 , ... The ... the Flex House, the next project in the company’s esteemed VISION House demonstration project ... homeowners use exactly the amount of resources they need to live affordably and abundantly ...
(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility in ... Kong to support teaching, learning and research. It is also the largest research centre ... Kong. , With an area of 620 square metres and more than 50 ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens ... of International Trade, the UK’s most prestigious award for business success. The ... of total revenues and has grown by a total of 400% over the ...
Breaking Medicine News(10 mins):